Ultima Genomics: Linda Ramirez
Linda Ramirez will join Ultima Genomics as chief legal officer. Previously, she was general counsel at Olink, now part of Thermo Fisher Scientific. Overall, she has almost 30 years of experience practicing law, including more than a decade in the life sciences and biotech industry. Ramirez holds a BS in journalism and mass communications as well as a JD from the University of Colorado Boulder.
Immunai: Mikael Dolsten
Immunai has named Mikael Dolsten to its board of directors. Dolsten was previously Pfizer's chief scientific officer and president of research and development. Prior to that, he held senior leadership roles at Wyeth, Boehringer Ingelheim, and AstraZeneca.
For additional recent items on executive appointments, promotions, and departures in the omics and molecular diagnostics space, please see the People in the News page on our website.